HedgePath Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch HedgePath Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) (NCT02354261) | HedgePath Pharmaceuticals, Inc. | 2015-08-07 |
Track HedgePath Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.